Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1529804

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1529804

Rare Cell Isolation Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, Instrument), By Cell Type (Circulating Tumor Cells, Stem Cells), By Technology, By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Rare Cell Isolation Market Growth & Trends:

The global rare cell isolation market size is anticipated to reach USD 3.46 billion by 2030, registering a CAGR of 9.71% from 2024 to 2030, according to a new report by Grand View Research, Inc. This is attributed to the continuous technological advancements, increasing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in cancer research. Furthermore, the isolation of rare stem cells is essential for regenerative medicine and stem cell therapy, thereby propelling the demand over the forecast period.

The COVID-19 pandemic has positively impacted the market by accelerating diagnostics and therapeutic research advancements. The urgent need to understand the virus and develop effective treatments has stimulated investment in cutting-edge cell isolation technologies, facilitating the rapid isolation and analysis of rare immune cells and circulating viral particles. Thus, the growing demand has driven innovation and collaboration across the biotech industry, resulting in enhanced single-cell analysis, liquid biopsy, and personalized medicine capabilities, boosting the demand for rare cell isolation over the forecast period.

The increasing prevalence of chronic diseases, especially cancer, has significantly increased the demand for rare cell isolation techniques. Isolation of these cells allows for early diagnosis, monitoring of treatment efficacy, and development of targeted therapies tailored to individual patients. By capturing and studying these rare cells, researchers and clinicians are anticipated to identify specific genetic mutations, recognize tumor behavior, and devise personalized treatment plans, ultimately improving patient outcomes and advancing the field of oncology. Thus, the growing demand for rare cells in predicting behavior is estimated to propel the market growth over the forecast period.

However, advanced rare cell isolation technologies, such as microfluidics and flow cytometry, often require significant investment. The high equipment, reagents, and maintenance costs can be prohibitive for many research institutions and clinical labs, limiting market expansion. In addition, the processes involved in rare cell isolation are technically complex, thus requiring specialized expertise and training. This complexity is anticipated to create a barrier to adoption, further hampering the market's growth.

Rare Cell Isolation Market Report Highlights:

  • The reagent & kits segment dominated the market in 2023 and is expected to grow at the fastest CAGR from 2024 to 2030. The cost-effectiveness of reagents and kits compared to more sophisticated and expensive equipment for cell isolation plays a significant role in their widespread adoption
  • The stem cell type segment held the largest share of 39.46% in 2023. The pharmaceutical and biotechnology industries rely heavily on isolated stem cells to screen for new drugs, study cellular responses, and assess the safety of potential treatments. This widespread application in research and industry underpins the segment dominance
  • The microfluidics-based techniques technology segment dominated the market in 2023. Continuous innovation & advancements in microfluidics technology contributed to its leading position in the market. Researchers and companies are developing new microfluidic devices and methods that offer improved performance, ease of use, and integration with other analytical tools. These advancements are driving widespread adoption and expanding the applications of microfluidics-based cell isolation
  • North America dominated the market in 2023 due to the growing cancer incidence, sedentary lifestyle, and rising prevalence of chronic diseases. On the other hand, Asia Pacific is anticipated to grow at the highest CAGR over the forecast period
Product Code: GVR-4-68040-359-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Products Segment
    • 1.2.2. Cell Type Segment
    • 1.2.3. Technology Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
    • 1.8.1. Total Market: CAGR Calculation
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Rare cell isolation market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic and rare diseases
      • 3.2.1.2. Technological advancement and innovation in cell isolation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Strict regulations and compliances for cell separation
  • 3.3. Rare Cell Isolation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Rare Cell Isolation Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Rare Cell Isolation Market Products Movement Analysis
  • 4.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Reagent & Kits
    • 4.4.1. Reagent & kits market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Instrument
    • 4.5.1. Instrument market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Rare Cell Isolation Market: Cell Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Rare Cell Isolation Market Application Movement Analysis
  • 5.3. Global Rare Cell Isolation Market Size & Trend Analysis, by cell type, 2018 to 2030 (USD Million)
  • 5.4. Circulating Tumor Cells
    • 5.4.1. Circulating tumor cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Stem Cells
    • 5.5.1. Stem cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Fetal Cells
    • 5.6.1. Fetal cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Rare Immune Cells
    • 5.7.1. Rare immune cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Circulating Endothelial Cells
    • 5.8.1. Circulating endothelial cells market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Other Rare Cell Types
    • 5.9.1. Other rare cell types market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Rare cell isolation market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Rare Cell Isolation Market Technology Movement Analysis
  • 6.3. Global Rare Cell Isolation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 6.4. Microfluidics-based Techniques
    • 6.4.1. Microfluidics-based techniques market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Fluorescence-activated Cell Sorting
    • 6.5.1. Fluorescence-activated cell sorting market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Magnetic Bead Separation
    • 6.6.1. Magnetic bead separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Rare cell isolation market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Competitive scenario
      • 7.5.8.3. Regulatory framework
      • 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key country dynamics
      • 7.5.9.2. Competitive scenario
      • 7.5.9.3. Regulatory framework
      • 7.5.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Competitive scenario
      • 7.8.4.3. Regulatory framework
      • 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key country dynamics
      • 7.8.5.2. Competitive scenario
      • 7.8.5.3. Regulatory framework
      • 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Miltenyi Biotec
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Danaher
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. QIAGEN N.V.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Bio-techne
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. STEMCELL Technologies
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. CELLENION
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. RareCyte
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Illumina, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Bio-Rad Laboratories, Inc.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
Product Code: GVR-4-68040-359-9

List of Tables

  • 1. List of abbreviation
  • 2. Global rare cell isolation market, by region, 2018 - 2030 (USD Million)
  • 3. Global rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 4. Global rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 5. Global rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 6. North America rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 7. North America rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 8. North America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 9. North America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 10. U.S. rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 11. U.S. rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 12. U.S. rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 13. Canada rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 14. Canada rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 15. Canada rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 16. Mexico rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 17. Mexico rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 18. Mexico rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 19. Europe rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 20. Europe rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 21. Europe rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 22. Europe rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 23. UK rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 24. UK rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 25. UK rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 26. Germany rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 27. Germany rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 28. Germany rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 29. France rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 30. France rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 31. France rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 32. Italy rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 33. Italy rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 34. Italy rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 35. Spain rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 36. Spain rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 37. Spain rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 38. Denmark rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 39. Denmark rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 40. Denmark rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 41. Sweden rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 42. Sweden rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 43. Sweden rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 44. Norway rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 45. Norway rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 46. Norway rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 47. Asia Pacific rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 48. Asia Pacific rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 49. Asia Pacific rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 50. Asia Pacific rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 51. Japan rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 52. Japan rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 53. Japan rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 54. China rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 55. China rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 56. China rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 57. India rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 58. India rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 59. India rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 60. Australia rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 61. Australia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 62. Australia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 63. South Korea rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 64. South Korea rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 65. South Korea rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 66. Thailand rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 67. Thailand rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 68. Thailand rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 69. Latin America rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 70. Latin America rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 71. Latin America rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 72. Latin America rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 73. Brazil rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 74. Brazil rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 75. Brazil rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 76. Argentina rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 77. Argentina rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 78. Argentina rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 79. MEA rare cell isolation market, by country, 2018 - 2030 (USD Million)
  • 80. MEA rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 81. MEA rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 82. MEA rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 83. South Africa rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 84. South Africa rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 85. South Africa rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 86. Saudi Arabia rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 87. Saudi Arabia rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 88. Saudi Arabia rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 89. UAE rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 90. UAE rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 91. UAE rare cell isolation market, by technology, 2018 - 2030 (USD Million)
  • 92. Kuwait rare cell isolation market, by product, 2018 - 2030 (USD Million)
  • 93. Kuwait rare cell isolation market, by cell type, 2018 - 2030 (USD Million)
  • 94. Kuwait rare cell isolation market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • 1. Rare cell isolation market segmentation
  • 2. Data analysis models
  • 3. Market formulation and validation
  • 4. Data validating & publishing
  • 5. Market research process
  • 6. Information procurement
  • 7. Primary research
  • 8. Value-chain-based sizing & forecasting
  • 9. QFD modelling for market share assessment
  • 10. Market formulation & validation
  • 11. Commodity flow analysis
  • 12. Market outlook
  • 13. Segment snapshot-1
  • 14. Segment snapshot-2
  • 15. Competitive landscape snapshot
  • 16. Market trends & outlook
  • 17. Porter's five force analysis
  • 18. PESTEL analysis
  • 19. Rare cell isolation market: Products outlook key takeaways
  • 20. Rare cell isolation market: Products movement analysis
  • 21. Reagent & kits market estimates and forecasts, 2018 - 2030 (USD Million)
  • 22. Instrument market estimates and forecasts, 2018 - 2030 (USD Million)
  • 23. Rare cell isolation market: Cell type outlook key takeaways
  • 24. Rare cell isolation market: Cell type movement analysis
  • 25. Circulating tumor cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 26. Stem cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 27. Fetal cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 28. Rare immune cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 29. Circulating endothelial cells market estimates and forecasts, 2018 - 2030 (USD Million)
  • 30. Other rare cell types market estimates and forecasts, 2018 - 2030 (USD Million)
  • 31. Rare cell isolation market: Technology outlook key takeaways
  • 32. Rare cell isolation market: Technology movement analysis
  • 33. Magnetic bead separation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 34. Fluorescence-activated cell sorting market estimates and forecasts, 2018 - 2030 (USD Million)
  • 35. Microfluidics-based techniques market estimates and forecasts, 2018 - 2030 (USD Million)
  • 36. Regional marketplace outlook, 2023 & 2030 (USD Million)
  • 37. Regional marketplace: Key takeaways
  • 38. North America rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 39. Key country dynamics
  • 40. U.S. rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 41. Key country dynamics
  • 42. Canada rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 43. Key country dynamics
  • 44. Mexico rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 45. Europe rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 46. Key country dynamics
  • 47. UK rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 48. Key country dynamics
  • 49. Germany rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 50. Key country dynamics
  • 51. France rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 52. Key country dynamics
  • 53. Spain rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 54. Key country dynamics
  • 55. Italy rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 56. Key country dynamics
  • 57. Denmark rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 58. Key country dynamics
  • 59. Sweden rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 60. Key country dynamics
  • 61. Norway rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 62. Asia Pacific rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 63. Key country dynamics
  • 64. Japan rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 65. Key country dynamics
  • 66. China rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 67. Key country dynamics
  • 68. India rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 69. Key country dynamics
  • 70. Australia rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 71. Key country dynamics
  • 72. South Korea rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 73. Key country dynamics
  • 74. Thailand rare cell isolation market estimates and forecasts, 2018 - 2030 (USD Million)
  • 75. Key country dynamics
  • 76. Market participant categorization
  • 77. Rare cell isolation market position analysis, 2023
  • 78. Strategic framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!